Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 Apr;19(4):682–685. doi: 10.1128/aac.19.4.682

Antiviral Activity of 2-Acetylpyridine Thiosemicarbazones Against Herpes Simplex Virus

Charles Shipman Jr 1, Sandra H Smith 1, John C Drach 1, Daniel L Klayman 2
PMCID: PMC181502  PMID: 6264853

Abstract

2-Acetylpyridine thiosemicarbazone derivatives inhibited the replication of herpes simplex virus types 1 and 2 to a greater extent than cellular deoxyribonucleic acid or protein synthesis.

Full text

PDF
682

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAUER D. J., STVINCENT L., KEMPE C. H., DOWNIE A. W. PROPHYLACTIC TREATMENT OF SMALL POX CONTACTS WITH N-METHYLISATIN BETA-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN). Lancet. 1963 Sep 7;2(7306):494–496. doi: 10.1016/s0140-6736(63)90230-7. [DOI] [PubMed] [Google Scholar]
  2. BAUER D. J. The antiviral and synergic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice. Br J Exp Pathol. 1955 Feb;36(1):105–114. [PMC free article] [PubMed] [Google Scholar]
  3. Ball C. R., van den Berg H. W., Poynter R. W. The measurement of radioactive precursor incorporation into small monolayer cultures. Methods Cell Biol. 1973;7:349–360. doi: 10.1016/s0091-679x(08)61786-0. [DOI] [PubMed] [Google Scholar]
  4. Bauer D. J. Clinical experience with the antiviral drug marboran (1-methylisatin 3-thiosemicarbazone). Ann N Y Acad Sci. 1965 Jul 30;130(1):110–117. doi: 10.1111/j.1749-6632.1965.tb12545.x. [DOI] [PubMed] [Google Scholar]
  5. Bauer D. J., St Vincent L., Kempe C. H., Young P. A., Downie A. W. Prophylaxis of smallpox with methisazone. Am J Epidemiol. 1969 Aug;90(2):130–145. doi: 10.1093/oxfordjournals.aje.a121057. [DOI] [PubMed] [Google Scholar]
  6. Brockman R. W., Sidwell R. W., Arnett G., Shaddix S. Heterocyclic thiosemicarbazones: correlation between structure, inhibition of ribonucleotide reductase, and inhibition of DNA viruses. Proc Soc Exp Biol Med. 1970 Feb;133(2):609–614. doi: 10.3181/00379727-133-34528. [DOI] [PubMed] [Google Scholar]
  7. Dobek A. S., Klayman D. L., Dickson E. T., Jr, Scovill J. P., Tramont E. C. Inhibition of clinically significant bacterial organisms in vitro by 2-acetylpyridine thiosemicarbazones. Antimicrob Agents Chemother. 1980 Jul;18(1):27–36. doi: 10.1128/aac.18.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drach J. C., Shipman C., Jr The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness? Ann N Y Acad Sci. 1977 Mar 4;284:396–409. doi: 10.1111/j.1749-6632.1977.tb21976.x. [DOI] [PubMed] [Google Scholar]
  9. Fujimoto W. Y., Teague J., Williams R. H. Fibroblast monolayer cultures in scintillation counting vials: metabolic and growth experiments using radioisotopes and a microfluoremetric DNA assay. In Vitro. 1977 Apr;13(4):237–244. doi: 10.1007/BF02615081. [DOI] [PubMed] [Google Scholar]
  10. HUTFIELD D. C., CSONKA G. W. MARBORAN IN HERPES GENITALIS. Lancet. 1964 Feb 8;1(7328):329–330. doi: 10.1016/s0140-6736(64)92446-8. [DOI] [PubMed] [Google Scholar]
  11. Heiner G. G., Fatima N., Russell P. K., Haase A. T., Ahmad N., Mohammed N., Thomas D. B., Mack T. M., Khan M. M., Knatterud G. L. Field trials of methisazone as a prophylactic agent against smallpox. Am J Epidemiol. 1971 Nov;94(5):435–449. doi: 10.1093/oxfordjournals.aje.a121340. [DOI] [PubMed] [Google Scholar]
  12. Klayman D. L., Bartosevich J. F., Griffin T. S., Mason C. J., Scovill J. P. 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem. 1979 Jul;22(7):855–862. doi: 10.1021/jm00193a020. [DOI] [PubMed] [Google Scholar]
  13. Klaymann D. L., Scovill J. P., Bartosevich J. F., Mason C. J. 2-Acetylpyridine thiosemicarbazones. 2. N4,N4-Disubstituted derivatives as potential antimalarial agents. J Med Chem. 1979 Nov;22(11):1367–1373. doi: 10.1021/jm00197a017. [DOI] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Shipman C., Jr, Drach J. C. Absence of adenosine deaminase activity in a mammalian cell line transformed by Rous sarcoma virus. Science. 1978 Jun 9;200(4346):1163–1165. doi: 10.1126/science.206965. [DOI] [PubMed] [Google Scholar]
  16. Shipman C., Jr Evaluation of 4-(2-hydroxyethyl)-1-piperazineëthanesulfonic acid (HEPES) as a tissue culture buffer. Proc Soc Exp Biol Med. 1969 Jan;130(1):305–310. doi: 10.3181/00379727-130-33543. [DOI] [PubMed] [Google Scholar]
  17. Shipman C., Jr, Smith S. H., Carlson R. H., Drach J. C. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures. Antimicrob Agents Chemother. 1976 Jan;9(1):120–127. doi: 10.1128/aac.9.1.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sidwell R. W., Arnett G., Dixon G. J., Schabel F. M., Jr Purine analogs as potential anticytomegalovirus agents. Proc Soc Exp Biol Med. 1969 Sep;131(4):1223–1230. doi: 10.3181/00379727-131-34075. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES